Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.

MLA

Furman, Wayne L., et al. “Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using Hu14.18K322A.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1391590910&authtype=sso&custid=ns315887.

APA

Furman, W. L., Furman, W. L., McCarville, B., Shulkin, B. L., Davidoff, A., Krasin, M., Hsu, C.-W., Pan, H., Wu, J., Brennan, R., Bishop, M. W., Helmig, S., Stewart, E., Navid, F., Triplett, B., Santana, V., Santiago, T., Hank, J. A., Gillies, S. D., … Federico, S. M. (2022). Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.

Chicago

Furman, Wayne L, Wayne L Furman, Beth McCarville, Barry L Shulkin, Andrew Davidoff, Matthew Krasin, Chia-Wei Hsu, et al. 2022. “Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using Hu14.18K322A.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1391590910&authtype=sso&custid=ns315887.